- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Polycythaemic Infants
Total 6096 results
-
Novartis PharmaceuticalsAvailable
-
AOP Orphan Pharmaceuticals AGPharmaEssentia Corporation (for the U.S.)CompletedPolycythemia VeraSpain, Austria, Bulgaria, France, Germany, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine, Czechia
-
Kartos Therapeutics, Inc.UnknownPolycythemia VeraUnited States, Poland, Spain, Germany, Hungary, France
-
ItalfarmacoCompletedPolycythemia VeraGermany, Poland, United Kingdom, Italy, France
-
Incyte CorporationNovartis PharmaceuticalsCompletedPolycythemia VeraUnited States, Canada, France, Italy, United Kingdom, China, Belgium, Germany, Spain, Turkey, Japan, Australia, Korea, Republic of, Netherlands, Russian Federation, Argentina, Thailand, Hungary
-
Incyte CorporationCompletedPolycythemia VeraUnited States, Belgium, Germany, Spain, Italy, United Kingdom, Ireland
-
AOP Orphan Pharmaceuticals AGPharmaEssentia (Co-Sponsor for USA)CompletedPolycythemia VeraSpain, Belgium, Austria, Italy, Bulgaria, Czech Republic, France, Germany, Hungary, Poland, Romania, Russian Federation, Slovakia, Ukraine
-
PV-NordCompleted
-
Ronald HoffmanNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumWithdrawnPolycythemia Vera
-
Consorzio Mario Negri SudAgenzia Italiana del Farmaco; A.O. Ospedale Papa Giovanni XXIIITerminated
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy, United Kingdom, France
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
Leiden University Medical CenterRecruitingTwin Anemia Polycythemia SequenceUnited States, Italy, Netherlands, Spain, Sweden
-
Novartis PharmaceuticalsCompleted
-
Protagonist Therapeutics, Inc.Enrolling by invitationPolycythemia VeraUnited States
-
Hoffmann-La RocheTerminatedPolycythemia VeraUnited States, Canada, Italy, Australia
-
Novartis PharmaceuticalsCompletedPolycythemia VeraHungary, Italy, Belgium, Germany, Spain, Korea, Republic of, Israel, Canada, Turkey, France, Australia, India
-
University of OklahomaOSI PharmaceuticalsTerminatedPolycythemia VeraUnited States
-
AOP Orphan Pharmaceuticals AGCompletedPolycythemia VeraAustria
-
AOP Orphan Pharmaceuticals AGPharmaEssentia Corporation (Co-Sponsor for USA)CompletedPolycythemia VeraAustria, Bulgaria, Czech Republic, France, Hungary, Poland, Slovakia, Ukraine
-
Sierra Oncology LLC - a GSK companyCompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, France, Canada, Germany, Australia
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada, Australia
-
University of Illinois at ChicagoWithdrawnVHL Gene Mutation | Polycythemia; Familial | Erythrocytosis; Familial | HIF-2alpha Erythrocytosis | PHD2 Erythrocytosis | Chuvash Erythrocytosis
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingPolycythemia Vera | MyelofibrosisUnited States
-
RWTH Aachen UniversityNovartis PharmaceuticalsActive, not recruitingPolycythemia Vera (PV) | Essential Thrombocythemia (ET)Germany
-
University of CopenhagenCompleted
-
Northwestern UniversityNational Cancer Institute (NCI)WithdrawnPrimary Myelofibrosis | Polycythemia Vera | Myelofibrosis | Thrombocytopenia
-
Bristol-Myers SquibbRecruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisKorea, Republic of
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisItaly
-
NS Pharma, Inc.Nippon Shinyaku Co., Ltd.TerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Thailand, Malaysia, Korea, Republic of, Italy, United Kingdom, Poland, Germany, Turkey
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisGermany
-
Novartis PharmaceuticalsCompletedIdiopathic Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia-Vera MyelofibrosisUnited Kingdom, Ireland, Germany, Italy, France
-
PharmaEssentiaNot yet recruitingPolycythemia Vera | Myeloproliferative Neoplasm
-
Third Military Medical UniversityRecruiting
-
Inha University HospitalCompletedPreterm Infants | Respiratory Distress Syndrome In Premature InfantsKorea, Republic of
-
Mansoura UniversityCompletedPreterm Infants | Respiratory Distress Syndrome | Premature Infants | Hyaline Membrane DiseaseEgypt
-
University of CalgaryCanadian Institutes of Health Research (CIHR); Alberta Economic Development...TerminatedMicrobiota | Gastrointestinal Microbiome | Infant, Premature | Infants, Extremely PrematureCanada
-
Incyte CorporationCompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States
-
Capital Medical UniversityNot yet recruiting
-
Sohag UniversityRecruiting
-
Multinational Center for Quality of Life Research...Not yet recruiting
-
Fondazione per la Ricerca Ospedale MaggioreAOP Orphan Pharmaceuticals AGCompleted
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Imago BioSciences, Inc., a subsidiary of Merck...CompletedMyelofibrosis | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (PPV-MF) | Post-essential Thrombocythemia Myelofibrosis (PET-MF)Germany, United States, Australia, Italy, United Kingdom
-
CTI BioPharmaTerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada, France, United Kingdom, Australia, Belgium, Germany, New Zealand, Netherlands, Russian Federation, Hungary, Czechia
-
Novartis PharmaceuticalsWithdrawnPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | PMF | Post-Essential Thrombocythemia Myelofibrosis
-
Novartis PharmaceuticalsCompletedAsian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MFPrimary Myelofibrosis (MF) | Post-Polycythemia Vera (PV) MF | Post-Essential Thrombocythemia (ET) MFTaiwan, Japan, Korea, Republic of, China
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy